Cambridge · Seed–Series A · 9 people tracked
Also known as CURIE BIO OPERATIONS, LLC · Curie Bio Seed
Investment thesis
Curie.Bio is a venture capital firm that invests in early-stage biotech therapeutics companies.
Source: firm website, verified Aug 25, 2026.
Team · 9 people
from curated & public directories
Founder mafia
3 people who came through Curie.Bio went on to found or lead other companies.
What they invest in
from 2 of 3 portfolio companiesBiotech ×2AI & Machine Learning ×1
HQs:United States×2
Investments · 3 tracked
founders shown can be your intro path
Improving patients' lives by accelerating development and commercialization of medicines that matter.
BiotechCambridge, US
Sanjiv K. Patel(Executive Officer, Director)Donald A. Bergstrom(Executive Officer)Thomas Catinazzo(Executive Officer)Peter Rahmer(Executive Officer)Sekar Kathiresan(Director)Douglas S. Ingram(Director)
Board seatAlexis Borisy· per SEC Form D · $30M raise · filed Jan 2024
Co-investorsCommonweal VenturesForesite Capital
Forward Therapeutics develops oral small-molecule medicines targeting inflammation-driven diseases, using a structure-based, data-driven discovery engine to design drugs against validated pathways.
AI & Machine LearningBiotech
Co-investorsOrbiMed
Social video analytics company providing cross-platform audience and content intelligence; acquired by Chartbeat in March 2023.
Mountain View, US
Robert Gabel(Executive Officer, Director)
BoardMatt Coffin(Director)Rick Heitzmann(Director)Allen DeBevoise(Director)Warren Lee(Director)
Co-investorsCanaan PartnersBling CapitalFifth WallFirstMark CapitalLerer HippeauMarker+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioRelay TherapeuticsNASDAQ: RLAY
Portfolio news
latest coverage across their companiesRelay Therapeutics · investing.com · Aug 20, 2026
Frequently asked questions
- What stage does Curie.Bio invest at?
- Curie.Bio invests at the Seed, Series A stages.
- What is Curie.Bio's typical check size?
- Curie.Bio typically writes checks of $7M.
- What sectors does Curie.Bio focus on?
- Curie.Bio focuses on Biotech.
- Where is Curie.Bio located?
- Curie.Bio is headquartered in Cambridge, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.